Crossmark

Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion

Published Online: 2019-06-18

Authors

Hase, Tomoki

Shishido, Syun

Yamamoto, So

Yamashita, Rei

Nukima, Haruka

Taira, Shu

Toyoda, Tsudoi

Abe, Keiko

Hamaguchi, Tsuyoshi

Ono, Kenjiro

Noguchi-Shinohara, Moeko

Yamada, Masahito

Kobayashi, Shoko
License Information

Text and Data Mining valid from 2019-06-18

Version of Record valid from 2019-06-18
More Information

Article History

Received: 18 December 2018

Accepted: 3 June 2019

First Online: 18 June 2019

Competing Interests

: The authors declare no competing interests.

Document is current